Eline Entertainment Group, Inc. (PINK:EEGI) and the company's subsidiary Let The Good Times Roll has successfully merged with Midnight Express. This is a second expansion merger for Let The Good Times Roll. Let The Good Times Roll's subsidiary Midnight Express is a Florida based luxury transportation company specializing in tours of the Tampa Bay area. Midnight Express was previously geared towards tours in the party bus atmosphere, which makes for a great synergistic merger with Let The Good Times Roll as the company expands both its business model and territory.
Let The Good Times Roll employs an organic expansion and acquisition strategy to increase revenue streams and expand into the market immediately. Besides organic expansion, the company continues to seek mergers, acquisitions, and participation in various joint ventures. Let The Good Times Rollcompany seeks to achieve aggressive business growth with several mergers in the near future.
This is Eline Entertainment Group's third merger announcement in the last several days, and a second merger for the Let The Good Times Roll.
The Board of Directors of ICICI Bank Limited (NYSE:IBN) at its meeting held at Mumbai, approved the audited accounts of the Bank for the quarter ended September 30, 2010. During the quarter, the Bank received approval of Reserve Bank of India (RBI) for merger of Bank of Rajasthan. The merger was effective from the close of business of August 12, 2010. The financials for Q2-2011 include the financials for erstwhile Bank of Rajasthan (e-BoR) for the period August 13, 2010 to September 30, 2010 (49 days). At the merger date, e-BoR had total assets of Rs. 15,596 crore (US$ 3.5 billion), advances of Rs. 6,528 crore (US$ 1.5 billion) and deposits of Rs. 13,483 crore (US$ 3.0 billion) including CASA deposits of Rs. 4,680 crore (US$ 1.0 billion).
ICICI Bank Limited provides banking products and financial services in the areas of investment banking, life and non-life insurance, venture capital, and asset management to corporate and retail customers.
Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, disclosed that Power3 has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in October or November 2010.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Rozetta-Cell has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Cathrin Petty as a non-executive Director. Cathrin was appointed unanimously by ICON's board of directors and, in accordance with ICON's Articles of Association, will stand for re-election by ICON's shareholders at the Company's next annual general meeting.
Cathrin is a Special Partner at Vitruvian Partners LLP and also serves as a Non Executive Director for the NHS (Strategic Health Authority for Greater London), a Non Executive Director for Circassia Ltd and an advisor to Merz Pharma GmBH
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries.
Iconix Brand Group, Inc. (Nasdaq:ICON), previously announced financial results for the third quarter ended September 30, 2010. Total revenue for the third quarter of 2010 was approximately $96.9 million, a 63% increase as compared to approximately $59.4 million for the third quarter of 2009.
Iconix Brand Group, Inc. owns, licenses and markets a growing portfolio of consumer brands including CANDIE'S (R), BONGO (R), BADGLEY MISCHKA (R), JOE BOXER (R) RAMPAGE (R) MUDD (R), LONDON FOG (R), MOSSIMO (R) OCEAN PACIFIC(R), DANSKIN (R) ROCA WEAR(R), CANNON (R), ROYAL VELVET (R), FIELDCREST (R), CHARISMA (R), STARTER (R) and WAVERLY (R).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Eline Entertainment Group, Inc. (EEGI.PK). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).